PORTLAND, Maine – (BUSINESS WIRE) – Rarebreed Veterinary Partners (“Rarebreed” or the “Company”), a technology-enabled veterinary services platform, announced today that it has closed a new round of funding led by existing investors Halle Capital Management and Trilantic North America’s leading private investors -Equity company. The investment will be used to support Rarebreed’s continued growth by acquiring additional veterinary clinics and improving services for the health teams within its network.
Rarebreed works with veterinary clinics to provide world-class tools and solutions that allow staff to focus on delivering the highest quality patient care. Founded in 2018, the company currently employs 800 people in 33 clinics in the Northeast, doubling its footprint since the company’s previous fundraising led by Trilantic North America in September 2020.
“At Rarebreed we are passionate about caring for the people who care for animals,” said Dan Espinal, CEO of Rarebreed Veterinary Partners. “We are excited to announce this new round of funding, which will enable us to continue providing exceptional work experience for zookeepers in our network while expanding our platform to reach even more people who have dedicated their careers to veterinary care. ”
/cloudfront-us-east-1.images.arcpublishing.com/gray/ANQOCD4EVFFZ7JYCJRA2NDYR6Q.png)
“Our goal is to enable veterinarians to focus on operating at the top of their profession while Rarebreed takes care of the rest,” said Sean Miller, COO of Rarebreed Veterinary Partners. “We believe this will make a significant difference not only to our patients, but also to the staff in our network.”
Espinal and Miller retain significant stakes in the business and will continue to lead the company through the next phase of growth.
“Dan and Sean’s leadership has been instrumental in Rarebreed’s rapid growth over the past three years,” said JP Gutfreund, Managing Partner at Halle Capital Management. “We were thrilled to be part of the company’s journey and look forward to supporting its continued expansion to enhance the work experience for veterinarians across the country.”
“The Rarebreed team continues to impress us with the execution of their strategy and the support of their partners in a high-growth environment,” said Jamie Manges, partner at Trilantic North America.
“We are excited to provide the team with additional capital to continue investing in the growing demand for animal health services,” added Ted Rosenwasser, Principal at Trilantic North America.
Gunderson Dettmer Stough Villeneuve Franklin and Hachigian, LLP advised Rarebreed on the transaction.
About Rarebreed Veterinary Partners
Rarebreed Veterinary Partners is a thriving community of veterinary clinics in the Northeast that values health teams and provides superior medical and compassionate care to pets. Rarebreed creates exceptional work experiences, one partnership at a time, and believes that when the health team thrives, economic and emotional wellbeing thrives. As a result, customers and pets get the veterinary experience they expect and deserve. Rarebreed’s goal is to become the employer of choice for those who dedicate their professional lives to veterinary care. Rarebreed does this through innovation and industry-leading benefits, including stock buy-in, oversized parental leave, pet medical benefits, and world-class health benefits. Rarebreed invests in business operations and a technology backend that provides extensive analysis of practices.
About Halle Capital Management
Halle Capital Management is a New York-based, growth stocks-focused investment firm providing capital and strategic guidance to healthcare, consumer and business services companies. We use our extensive experience, our solid professional network, our collaborative mindset and our deep understanding of growth drivers to work with business-oriented management teams. Further information is available at www.hallecapital.com.
About the trilantic North America
Trilantic Capital Management LP (“Trilantic North America”) is a leading, growth-oriented, medium-sized private equity firm focused on control and significant minority interests in North America. Trilantic North America’s primary investment focus is in business services, consumers and energy. Trilantic North America has six private equity fund families with total capital of $ 9.7 billion. Trilantic North America was recognized by Inc. Magazine’s Top 50 Founder-Friendly Private Equity Firms for 2019. More information is available at www.trilanticnorthamerica.com.
